Current evidence suggests that FBLN1 plays a tumour suppressive role not only in gastric cancer but also in other cancers such as breast cancer and prostate cancer (Pupa et al, 2004; Wlazlinski et al, 2007). This evidence concerns the gene FBLN1 and breast cancer.